Debiopharm Innovation Fund invests in MedaSystems
We are pleased to announce additional funding from Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, motivated by their vision of patient centric, data-enabled clinical research and enabling patients to access novel treatments sooner.
MedaSystems closes Seed Funding
We’re very pleased to share with you that MedaSystems has closed a seed funding round, in order to continue to grow our market and further build out the platform.
MedaSystems Demonstrates Continued Commitment to Protecting Expanded Access Data with Successful SOC 2 Type 2 Audit
We are thrilled to announce the successful completion of a Service Organization Control (SOC) 2 Type 2 audit. As industry leaders in the SaaS Expanded Access software sector, this accomplishment underscores our unwavering commitment to data security, patient privacy, and regulatory compliance.
Young Sohn joins MedaSystems’ advisory board
Industry veteran, Young Sohn, joins the advisory board of MedaSystems.
MedaSystems receives SOC 2 Type 1 certification
We are pleased to share that we’ve been SOC2 Type 1 certified.
MedaSystems welcomes Dr. Jean Godin as advisor
Dr. Jean Godin joins MedaSystems as a strategic advisor.
MedaSystems welcomes Lisa Suennen to board of advisors
We’re thrilled to announce that Lisa Suennen has joined our board of advisors. Ms. Suennen is the President of Digital and Data Solutions at Canary Medical. She brings her deep expertise in digital health, technology, and life sciences to bear on MedaSystems’ mission to help life science companies collaborate with physicians and their patients seeking early access to investigational medicines.
MedaSystems announces pre-seed funding raise
MedaSystems announces the close of a pre-seed funding round, led by nina capital.
Industry trends, designing for international markets and being mission-driven: a conversation with M.R. Rangaswami
A conversation about pharma industry trends and building MedaSystems, between Fiona Smythe and M.R. Rangaswami of Sandhill.com.
